A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

September 2, 2025

Study Completion Date

September 2, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin Lispro-aabc

Administered SC

DRUG

Insulin Glargine

Administered SC

Trial Locations (12)

208020

Brij Medical Center Pvt. Ltd., Kanpur

302033

Rajasthan University of Health Sciences, Jaipur

334003

S. P. Medical College & A G Hospital, Bikaner

380007

Vijyaratna Dibetes Diagnosis Treatment Centre, Ahmedabad

411004

Sahyadri Super Speciality Hospital, Pune

411021

Chellaram Diabetes Institute, Pune

500012

Osmania Medical College & Hospital, Hyderabad

530002

King George Hospital, Visakhapatnam, Visakhapatnam

560043

Center for Diabetes and Endocrine Care, Bengaluru

600013

Diabetes Research Centre, Royapuram

641009

Kovai Diabetes Speciality Center and Hospital, Coimbatore

700073

Medical College & Hospital, Kolkata, Kolkata

All Listed Sponsors
collaborator

Cipla Ltd.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT06370715 - A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India | Biotech Hunter | Biotech Hunter